Viewing Study NCT03232203


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2026-03-12 @ 7:08 PM
Study NCT ID: NCT03232203
Status: COMPLETED
Last Update Posted: 2023-11-14
First Post: 2017-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Effectiveness of STRIMVELIS Risk Minimization Measures (RMMs)
Sponsor: Fondazione Telethon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Combined Immunodeficiency Due to ADA Deficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human leukocyte antigen View
None Key Risk Message View
None ADA-SCID View
None Health care providers View